NAMPT and diabetes mellitus: There is evidence of statistically significant lower mean concentrations of visfatin in patients with correct level of glycemia, without diabetes mellitus type 2 in relation to mean concentrations in patients with obesity or overweight, with an elevated level of glycemia, as well as diabetes mellitus type 2.